TELA Bio, Inc. (TELA) Misses Q4 EPS by 11c

TELA Bio, Inc. (NASDAQ: TELA) reported Q4 EPS of ($0.53), $0.11 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $17 million versus the consensus estimate of $16.39 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Lumentum shares rise on analyst upgrades, AI demand outlook